HLA class II defects in burkitt lymphoma: Bryostatin-1-Induced 17kDa protein restores CD4+ T-cell recognition

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Hossain, Azim ^a,b,c   God, Jason M ^a,b,c   Radwan, Faisal F Y ^a,b,c   Amria, Shereen ^a,b,c   Zhao, Dan ^a,b,c   Bethard, Jennifer R ^b,c   Haque, Azizul ^a,b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BRYOSTATIN 1; CD4 ANTIGEN; HLA ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; PROTEIN KINASE C; ANTINEOPLASTIC AGENT; BRYOSTATIN; HLA D ANTIGEN; INTERLEUKIN 2;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BURKITT LYMPHOMA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENICITY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGEN PRESENTATION; ANTINEOPLASTIC AGENTS; BRYOSTATINS; BURKITT LYMPHOMA; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; HLA-D ANTIGENS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

EID: 84855604403     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/780839     Document Type: Article

References (43)

1. Brady G., MacArthur G. J., Farrell P. J., Epstein-Barr virus and Burkitt lymphoma Postgraduate Medical Journal 2008 84 993 372 377
2. Perkins A. S., Friedberg J. W., Burkitt lymphoma in adults Hematology 2008 341 348
3. Biko D. M., Anupindi S. A., Hernandez A., Kersun L., Bellah R., Childhood Burkitt lymphoma: abdominal and pelvic imaging findings American Journal of Roentgenology 2009 192 5 1304 1315
4. Yustein J. T., Dang C. V., Biology and treatment of Burkitt's lymphoma Current Opinion in Hematology 2007 14 4 375 381 (Pubitemid 46842812)
5. Kawa K., Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease International Journal of Hematology 2003 78 1 24 31 (Pubitemid 36899898)
6. Snow A. L., Martinez O. M., Epstein-Barr virus: evasive maneuvers in the development of PTLD American Journal of Transplantation 2007 7 2 271 277 (Pubitemid 46096319)
7. Ambinder R. F., Epstein-barr virus and hodgkin lymphoma Hematology 2007 204 209
8. Ohtsubo H., Arima N., Tei C., Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia Leukemia and Lymphoma 1999 33 5-6 451 458 (Pubitemid 29213603)
9. Dang C. V., O'Donnell K. A., Zeller K. I., Nguyen T., Osthus R. C., Li F., The c-Myc target gene network Seminars in Cancer Biology 2006 16 4 253 264 (Pubitemid 44311039)
10. Bellan C., Lazzi S., Hummel M., Palummo N., De Santi M., Amato T., Nyagol J., Sabattini E., Lazure T., Pileri S. A., Raphael M., Stein H., Tosi P., Leoncini L., Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas Blood 2005 106 3 1031 1036 (Pubitemid 41076450)
11. Dave S. S., Fu K., Wright G. W., Lam L. T., Kluin P., Boerma E. J., Greiner T. C., Weisenburger D. D., Rosenwald A., Ott G., Mller-Hermelink H. K., Gascoyne R. D., Delabie J., Rimsza L. M., Braziel R. M., Grogan T. M., Campo E., Jaffe E. S., Dave B. J., Sanger W., Bast M., Vose J. M., Armitage J. O., Connors J. M., Smeland E. B., Kvaloy S., Holte H., Fisher R. I., Miller T. P., Montserrat E., Wilson W. H., Bahl M., Zhao H., Yang L., Powell J., Simon R., Chan W. C., Staudt L. M., Molecular diagnosis of Burkitt's lymphoma New England Journal of Medicine 2006 354 23 2431 2442 (Pubitemid 43855046)
12. Gerbitz A., Mautner J., Geltinger C., Hrtnagel K., Christoph B., Asenbauer H., Klobeck G., Polack A., Bornkamm G. W., Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma Oncogene 1999 18 9 1745 1753 (Pubitemid 29137465)
13. Frisan T., Levitsky V., Polack A., Masucci M. G., Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines Journal of Immunology 1998 160 7 3281 3289 (Pubitemid 28164718)
14. Sharipo A., Imreh M., Leonchiks A., Imreh S., Masucci M. G., A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I B with the proteasome: a new mechanism for selective inhibition of proteolysis Nature Medicine 1998 4 8 939 944 (Pubitemid 28364034)
15. Yin Y., Manoury B., Fhraeus R., Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1 Science 2003 301 5638 1371 1374 (Pubitemid 37075811)
16. Masucci M. G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E., Klein G., Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines Proceedings of the National Academy of Sciences of the United States of America 1987 84 13 4567 4571 (Pubitemid 17097854)
17. Gavioli R., De Campos-Lima P. O., Kurilla M. G., Kieff E., Klein G., Masucci M. G., Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down- regulation of HLA-A11 in Burkitt lymphoma Proceedings of the National Academy of Sciences of the United States of America 1992 89 13 5862 5866
18. Jilg W., Voltz R., Markert-Hahn C., Mairhofer H., Munz I., Wolf H., Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells Cancer Research 1991 51 1 27 32
19. Ressing M. E., van Leeuwen D., Verreck F. A., Gomez R., Heemskerk B., Toebes M., Mullen M. M., Jardetzky T. S., Longnecker R., Schilham M. W., Ottenhoff T. H. M., Neefjes J., Schumacher T. N., Hutt-Fletcher L. M., Wiertz E. J. H. J., Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition Proceedings of the National Academy of Sciences of the United States of America 2003 100 20 11583 11588 (Pubitemid 37205979)
20. Ressing M. E., van Leeuwen D., Verreck F. A., Keating S., Gomez R., Franken K. L. M. C., Ottenhoff T. H. M., Spriggs M., Schumacher T. N., Hutt-Fletcher L. M., Rowe M., Wiertz E. J. H. J., Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion Journal of Virology 2005 79 2 841 852 (Pubitemid 40053867)
21. Gao F. G., Khammanivong V., Liu W. J., Leggatt G. R., Frazer I. H., Fernando G. J. P., Antigen-specific CD4 + T-cell help is required to activate a memory CD8 + T cell to a fully functional tumor killer cell Cancer Research 2002 62 22 6438 6441 (Pubitemid 35364102)
22. Amria S., Cameron C., Stuart R., Haque A., Defects in HLA class II antigen presentation in B-cell lymphomas Leukemia and Lymphoma 2008 49 2 353 355 (Pubitemid 351193932)
23. Do Y., Hegde V. L., Nagarkatti P. S., Nagarkatti M., Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells Cancer Research 2004 64 18 6756 6765 (Pubitemid 39297939)
24. Kudinov Y., Wiseman C. L., Kharazi A. I., Phorbol myristate acetate and bryostatin 1 rescue IFN-gamma inducibility of MHC class II molecules in LS1034 colorectal carcinoma cell line Cancer Cell International 2003 3, article 4
25. Haque M. A., Hawes J. W., Blum J. S., Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition Journal of Immunology 2001 166 7 4543 4551 (Pubitemid 32233739)
26. Haque A., Hajiaghamohseni L. M., Li P., Toomy K., Blum J. S., Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells Cellular Immunology 2007 249 1 20 29
27. Hiraiwa A., Yamanaka K., Kwok W. W., Mickelson E. M., Masewicz S., Hansen J. A., Radka S. F., Nepom G. T., Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis Proceedings of the National Academy of Sciences of the United States of America 1990 87 20 8051 8055
28. Ma C., Whiteley P. E., Cameron P. M., Freed D. C., Pressey A., Chen S. L., Garni-Wagner B., Fang C., Zaller D. M., Wicker L. S., Blum J. S., Role of APC in the selection of immunodominant T cell epitopes Journal of Immunology 1999 163 12 6413 6423
29. Pathak S. S., Blum J. S., Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules Traffic 2000 1 7 561 569
30. Haque M. A., Li P., Jackson S. K., Zarour H. M., Hawes J. W., Phan U. T., Maric M., Cresswell P., Blum J. S., Absence of -interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes Journal of Experimental Medicine 2002 195 10 1267 1277 (Pubitemid 34564329)
31. Younger A. R., Amria S., Jeffrey W. A., Mahdy A. E. M., Goldstein O. G., Norris J. S., Haque A., HLA class II antigen presentation by prostate cancer cells Prostate Cancer and Prostatic Diseases 2008 11 4 334 341
32. Goldstein O. G., Hajiaghamohseni L. M., Amria S., Sundaram K., Reddy S. V., Haque A., Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma Cancer Immunology, Immunotherapy 2008 57 10 1461 1470
33. Amria S., Hajiaghamohseni L. M., Harbeson C., Zhao D., Goldstein O., Blum J. S., Haque A., HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition European Journal of Immunology 2008 38 7 1961 1970
34. Hill C. M., Liu A., Marshall K. W., Mayer J., Jorgensen B., Yuan B., Cubbon R. M., Nichols E. A., Wicker L. S., Rothbard J. B., Exploration of requirements for peptide binding to HLA DRB10101 and DRB10401 Journal of Immunology 1994 152 6 2890 2898 (Pubitemid 24097986)
35. Khanna R., Burrows S. R., Thomson S. A., Moss D. J., Cresswell P., Poulsen L. M., Cooper L., Class I processing-defective burkitt's lymphoma cells are recognized efficiently by CD4 + EBV-specific CTLs Journal of Immunology 1997 158 8 3619 3625 (Pubitemid 127488714)
36. Matloubian M., Concepcion R. J., Ahmed R., CD4 + T cells are required to sustain CD8 + cytotoxic T-cell responses during chronic viral infection Journal of Virology 1994 68 12 8056 8063 (Pubitemid 24362694)
37. Mi J. Q., Manches O., Wang J., Perron P., Weisbuch S., Marche P. N., Renversez J. C., Bensa J. C., Sotto J. J., Cahn J. Y., Leroux D., Bonnefoix T., Development of autologous cytotoxic CD4 + T clones in a human model of B-cell non-Hodgkin follicular lymphoma British Journal of Haematology 2006 135 3 324 335 (Pubitemid 44488535)
38. Khalil H., Deshaies F., Bellemare-Pelletier A., Brunet A., Faubert A., Azar G. A., Thibodeau J., Class II transactivator-induced expression of HLA-DO in Hela cells Tissue Antigens 2002 60 5 372 382 (Pubitemid 36020794)
39. Staege M. S., Lee S. P., Frisan T., Mautner J., Scholz S., Pajic A., Rickinson A. B., Masucci M. G., Polack A., Bornkamm G. W., MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 7 4550 4555 (Pubitemid 34286022)
40. Aldoss I. T., Weisenburger D. D., Fu K., Chan W. C., Vose J. M., Bierman P. J., Bociek R. G., Armitage J. O., Adult Burkitt lymphoma: advances in diagnosis and treatment Oncology 2008 22 13 1508 1517
41. Thomas D. A., Faderl S., O'Brien S., Bueso-Ramos C., Cortes J., Garcia-Manero G., Giles F. J., Verstovsek S., Wierda W. G., Pierce S. A., Shan J., Brandt M., Hagemeister F. B., Keating M. J., Cabanillas F., Kantarjian H., Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia Cancer 2006 106 7 1569 1580
42. Oriol A., Ribera J. M., Bergua J., Mesa E. G., Grande C., Esteve J., Brunet S., Moreno M. J., Escoda L., Hernandez-Rivas J. M., Hoelzer D., High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients Cancer 2008 113 1 117 125 (Pubitemid 351976392)
43. Gea-Banacloche J. C., Rituximab-associated infections Seminars in Hematology 2010 47 2 187 198